Abcam Company
Abcam helps researches with breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.
Estimated Revenue:
$50M to $100M
Industry:
Omics-based, Systemic
Investors Number:
6
Number Of Exists:
1001-5000
Technology:
Research Kit or Other Laboratory Practice Supplies
Founded Date:
1998
Headquarters:
Cambridge, United Kingdom
Total Funding:
$37.7M
Last Funding Type:
Series B